drugset / Trial / NCT00209859

Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis

NCT00209859

Phase 4 Completed 160 enrolled Hvidovre University Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate whether cyclosporine, added to methotrexate and steroid, increases the possibility of inflammatory management early in the disease; furthermore to investigate the possible steroid-sparing effect of cyclosporine in patients with recently diagnosed rheumatoid arthritis.

Timeline

Start
1998-10
Primary completion
Completion
2007-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide
Background Betamethasone Other / unclassified 28 mg Other
Background Methotrexate Small molecule

Indications